Create value, find new sources of profit; gained in productivity ... The globalisation of markets imposes its new rules. Having activated the first levers: concentrations, economies of scale, staff cuts, outsourcing, companies reach a landing. To go farther, new valuable sources are to be found in the organization of the structures, still too vertical, or «in silo ". Marketing functions and communication are primarily concerned, but it is all the company, from the R&D to finances, that can take advantage of an "injection" of transversality.

1. Sociology
and
Pharma Organizations
Joseph Pategou
International Strategy and Influence
joseph.pategou@skema.edu

2. 09/09/2016
Sociology and Pharma Organizations – Joseph Pategou
2
SUMMARY
I. Why Sociology of Organization?
II. Which Organizations?
Information about the author
Sources

3. WHY
3
Sociology of Organizations
Sociology and Pharma Organizations – Joseph Pategou

4. Create Value
4
Profit and Productivity
1
2 Sociology and Pharma Organizations – Joseph Pategou

5. Globalization
5
3
organization
Complexity
4 Sociology and Pharma Organizations – Joseph Pategou

6. 6
More
Cross-Functional
organization
Sociology and Pharma Organizations – Joseph Pategou

7. Which Organizations
7
Sociology and Pharma Organizations – Joseph Pategou

8. 8
“Transversality is applicable in the
pharmaceutical industry: The traditional
organizations were vertical, this came from
the Taylorism. But the only obstacle is the
notion of risk, high risk in an organization
maintains its vertical character”
Mr. François Dupuy
Sociologist of Organizations
Sociology and Pharma Organizations – Joseph Pategou

9. 9
• Innovated by creating six position corresponding to transversal projects in
the company
• Missions of four to six months
• Combines several skills (marketing, economy of the health...)
Jean-Baptiste Labrusse, HR Lilly
“ This is a real cultural revolution. We operate a transversal approach, but
we want to go much further, as we seek to establish a new business model
and foster innovation.”
The overall marketing, the organization "franchises" by therapeutic areas, remains in
force. But again the cross is a real plus, especially given the company's size. It is a question of
putting in synergy the good things which are made within the franchises, the best realizations,
to avoid reinventing the wheel, saving time and minimizing the costs. Several positions are so
devoted specifically to ensure that operational cross.
Beyond expertise, these employees must have a special ability to manage complexity or
ambiguity. And also know how to sort out a lot of information, synthesize it, make it
"actionable" and have an open mind.
Sociology and Pharma Organizations – Joseph Pategou

10. 10
In large companies like Novartis and Johnson & Johnson, the idea is
necessary to create at corporate level real project management
structures, with real decision-making power and influence.
The sought profiles are seniors with a work experience made in a
particular domain.
But a vision of the whole cycle of development of the drug, from the
animal models to the registration, and who are going to know how to
work with people having skill in strategy, galenic, and marketing.
development.
Sociology and Pharma Organizations – Joseph Pategou

11. 09/09/2016
11
Information about the author
I am fascinated by healthcare and the experience
of many companies to develop new types of drug
with the aim of saving lives around the world.
Main topics of passion in the healthcare:
- Strategy
- Digital
- Innovation
- Biosimilars
If you want to know more, please contact me:
joseph.pategou@skema.edu
M. Joseph Pategou
Sociology and Pharma Organizations – Joseph Pategou

12. 09/09/2016
12
THANK YOU FOR YOUR
ATTENTION
Sociology and Pharma Organizations – Joseph Pategou

13. Sources
13
Sociology and Pharma Organizations – Joseph Pategou

14. Sources
1. https://www.mysciencework.com/news/4491/etat-des-lieux-sur-le-systeme-de-sante-en-afrique
2. http://apps.who.int/iris/bitstream/10665/112816/1/WHO_HIS_HSI_14.1_fre.pdf#page=1&zoom=auto,-178,680
3. http://apps.who.int/iris/bitstream/10665/112816/1/WHO_HIS_HSI_14.1_fre.pdf?ua=1
4. http://baobabguides.com/fr/2010/08/18/l%E2%80%99afrique-lance-sa-production-de-medicaments-generiques/
5. http://baobabguides.com/fr/2010/08/18/l%E2%80%99afrique-lance-sa-production-de-medicaments-generiques/
6. Source : Xerfi 700
7. PHARMACEUTIQUES - MAI 2008 : La transversalité : plus qu’un concept, une réponse
8. http://martinwinckler.com/spip.php?article675
14
Sociology and Pharma Organizations – Joseph Pategou